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plerixafor and G-CSF have similar immune reconstitution at
30 and 60 days post autologous transplantation compared to
patients mobilized with G-CSF alone.LATE EFFECTS/QUALITY OF LIFE/PSYCHOSOCIAL ISSUES
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Background: HCT is a lengthy, complex procedure with the
potential for decreased quality of life, transplant related
mortality, relapsed disease, and graft-versus-host disease.
Psychosocial assessments are a part of the overall HCT eval-
uation process, but there are very few validated psychosocial
instruments for this patient population. Recently, the SIPAT
has been shown to predict outcomes in solid organ trans-
plantation. A retrospective pilot study was performed on 25
consecutive HCT patients to investigate whether SIPAT re-
sults correlated with HCT outcomes.
Methods: The retrospective pilot study was modeled after
methodology published in any earlier SIPAT study conducted
by JR Maldonado (Psychosomatics, 2012). Two experienced
HCT reviewers, a physician and a social worker, and an
inexperienced reviewer, a transplant coordinator, conducted
the retrospective chart review, completing the SIPAT for 25
consecutive HCT recipients at the University of Virginia be-
tween January and October 2012. A clinical research coor-
dinator independently reviewed each patient’s medical
records and interviewed transplant coordinators to record
HCT recipient outcomes.
Results: HCT recipients (median age 52, 56% male) received
HCT’s for myeloma, lymphoma and leukemia. 14 recipients
received an allogeneic transplant, while 11 received an
autologous one. The inter-rater reliability between the
SIPAT reviewers was inconsistent. 2 reviewers correlated
well (R¼.84), while the other correlations between re-
viewers were weak (R¼.62 and R¼.55). It was noted that
there was a response shift in SIPAT reviewer 3 to lower
scores, indicating potential bias in reviewers 1 and 2 due to
prior patient exposure. To test possible associations of
psychosocial assessments with recipient outcomes, indi-
vidual reviewer SIPAT scores were plotted. These indicated
higher assessment scores were associated with poorer so-
cial support and compliance, and increased drug relapses,
and psychiatric symptoms. Other outcome measures such
as graft failure, treatment related mortality, re-hospitali-
zation and disease relapse failed to show a relationship
with SIPAT scores.
Conclusion: SIPAT scores may indicate positive relation-
ships between HCT psychosocial assessments and various
psychosocial outcomes. Due to the limited number of
transplant recipients in the retrospective review, it was
not possible to completely blind the experiencedreviewers. Bias may have been introduced resulting in
higher scores for these reviewers compared to the third
reviewer, who was new to the program. Additionally, the
poor inter-rater reliability of the SIPAT (in spite of educa-
tion and practice) may have arisen from the challenges of
scoring patients retrospectively through chart reviews, as
the program’s psychosocial assessment was not as detailed
as the SIPAT. These issues can be addressed in future
prospective studies.204
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Background: Through the use of an electronic medical re-
cord (EMR) based system, care managers, and single provider
physician oversight, we previously reported high concor-
dance rates of post hematopoietic stem cell transplant
(HSCT) screening based on ASBMT guidelines in a commu-
nity based, multi-facility care delivery system.
Objective: To demonstrate that case management in a
vertically integrated, EMR based community practice span-
ning 9 medical centers in a large metropolitan region can
consistently promote high concordance rates with published
ASBMT guidelines and lead to timely recognition of common
transplant associated complications.
Methods: Retrospective chart review of 74 consecutive pe-
diatric HSCT survivors (0-18yrs) from 2005-2013 looking for
concordance rates with 2012 ASBMT late effects guidelines.
The frequency of thyroid dysfunction, cataracts, pulmonary
disease, and ovarian dysfunction were noted as well as the
mean time to development. Majority of patients were treated
with fractionated TBI and therefore were at high risk of
developing late effects.
Results: We observed a sustained high level of concordance
(>90%) with screening guidelines in the period after a pop-
ulation care management approach was implemented
(2009-2013). This led to the timely identiﬁcation and man-
agement of HSCT associated complications.
Conclusion: An EMR based, vertically integrated health care
system facilitates effective community based post-HSCT
survivorship care in the pediatric population.205
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Background: Patients of stem cell transplantation (SCT) may
experience long-term symptoms that impact quality of life
and adjustment. Employment status has been identiﬁed as
an important marker for post-transplant adjustment.
